Skip to main content
Caplight Logo









TellBio Inc.

TellBio Inc.

Private
Beverly, MassachusettsHealthcare & Life Scienceshttps://tellbio.com/

Last Round

Seed Round

Mar 24, 2026

Total Funding Raised

$10.27M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

TellBio Inc. is a biotechnology company that provides a liquid biopsy platform to revolutionize the detection and treatment of cancer through its circulating tumor cells (CTCs) technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

circulating tumor cellsCTCliquid biopsymicrofluidicscancer diagnosticsmetastatic cancerdrug developmentprecision medicinebiotechlab-on-a-chiponcology researchbiomarker discoverytherapeutic responsecancer monitoringtranslational medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TellBio Inc. Comparables

Compare TellBio Inc. with similar companies based on industry and business-model similarity.

TellBio Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioFluidica
81%
Rarecells
81%
Cell Microsystems
78%

TellBio Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundMar 24, 2026
VC RoundJul 6, 2024
Series A ExtensionMar 29, 2023
Series AMay 10, 2021
SeedFeb 5, 2021
Seed
Nov 4, 2019

TellBio Inc. Investors

Notable investors and investment history

TellBio Inc. investors
InvestorRounds
National Foundation for Cancer ResearchVC Round, Series A
Crocker VenturesVC Round, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 68% MoM.

  • May 10, 2021

    $5M round completed.

TellBio Inc. Filings

Explore SEC and related filing metadata, where available.

TellBio Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TellBio Inc.'s valuation, stock price, and market status.

Is TellBio Inc. a public or private company?

TellBio Inc. is a private company.

What is the current stock price of TellBio Inc.?

TellBio Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is TellBio Inc. worth (valuation)?

Valuation information for TellBio Inc. is not publicly available.

Can I buy TellBio Inc. stock?

TellBio Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was TellBio Inc.'s last funding round?

TellBio Inc.'s most recent funding round was Seed Round on March 24, 2026.

Who are the main investors in TellBio Inc.?

Key investors in TellBio Inc. include National Foundation for Cancer Research, Crocker Ventures.

Will TellBio Inc. IPO soon?

No public IPO plans have been announced for TellBio Inc..

How can I track TellBio Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TellBio Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeverly, Massachusetts
Employee Range4
Year Founded2021
Last FundingMar 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?